Cargando…

Targeting ferroptosis with miR-144-3p to attenuate pancreatic β cells dysfunction via regulating USP22/SIRT1 in type 2 diabetes

BACKGROUND: Recently, ferroptosis has been implicated in the pathologic process of several diseases including type 2 diabetes mellitus (T2DM). However, molecular mechanisms underlying ferroptosis in T2DM remain obscure. METHODS: Twenty four mice were included in this study. T2DM model mice were esta...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Shanshan, Liu, Xiao, Wang, Jihong, Yuan, Fengjuan, Liu, Yali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9235078/
https://www.ncbi.nlm.nih.gov/pubmed/35761309
http://dx.doi.org/10.1186/s13098-022-00852-7
_version_ 1784736229294604288
author Zhang, Shanshan
Liu, Xiao
Wang, Jihong
Yuan, Fengjuan
Liu, Yali
author_facet Zhang, Shanshan
Liu, Xiao
Wang, Jihong
Yuan, Fengjuan
Liu, Yali
author_sort Zhang, Shanshan
collection PubMed
description BACKGROUND: Recently, ferroptosis has been implicated in the pathologic process of several diseases including type 2 diabetes mellitus (T2DM). However, molecular mechanisms underlying ferroptosis in T2DM remain obscure. METHODS: Twenty four mice were included in this study. T2DM model mice were established by a high-fat diet combined with streptozotocin injection. INS-1 cells were stimulated with high glucose (HG). Cell viability was detected by CCK-8 kit. The levels of GSH, MDA, iron, and lipid ROS, and SOD activity, were detected by the corresponding kits. The interaction between miR-144-3p and USP22 was validated by dual-luciferase reporter assay. The relationship between USP22 and its substrate was verified using Co-IP and ubiquitination assays. The mRNA and protein expressions were examined by RT-qPCR and western blot, respectively. The functions of β cells in vitro and in vivo were evaluated glucose-stimulated insulin secretion test and HOMA-β, respectively. RESULTS: Ferroptosis occurred in the pancreas of T2DM mice and HG-induced INS-1 cells. Silencing miR-144-3p blocked the effect of HG on the cell viability and accumulation of lipid peroxides, thereby improving the insulin secretion in INS-1 cells. Mechanistically, USP22 is a direct target of miR-144-3p, which could stabilize SIRT1 expression, thereby suppressing ferroptosis. Overexpressing USP22 attenuated deleterious roles of HG in INS-1 cells; but its roles were reversed by up-regulating miR-144-3p. In vivo study demonstrated that miR-144-3p antagomir exerted an anti-hyperglycemic effect and regulated the ferroptosis-related proteins in the pancreas. CONCLUSION: The up-regulation of miR-144-3p suppressed USP22/SIRT1 to induce ferroptosis, which causes pancreatic β cells dysfunction, thereby promoting T2DM development. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13098-022-00852-7.
format Online
Article
Text
id pubmed-9235078
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-92350782022-06-28 Targeting ferroptosis with miR-144-3p to attenuate pancreatic β cells dysfunction via regulating USP22/SIRT1 in type 2 diabetes Zhang, Shanshan Liu, Xiao Wang, Jihong Yuan, Fengjuan Liu, Yali Diabetol Metab Syndr Research BACKGROUND: Recently, ferroptosis has been implicated in the pathologic process of several diseases including type 2 diabetes mellitus (T2DM). However, molecular mechanisms underlying ferroptosis in T2DM remain obscure. METHODS: Twenty four mice were included in this study. T2DM model mice were established by a high-fat diet combined with streptozotocin injection. INS-1 cells were stimulated with high glucose (HG). Cell viability was detected by CCK-8 kit. The levels of GSH, MDA, iron, and lipid ROS, and SOD activity, were detected by the corresponding kits. The interaction between miR-144-3p and USP22 was validated by dual-luciferase reporter assay. The relationship between USP22 and its substrate was verified using Co-IP and ubiquitination assays. The mRNA and protein expressions were examined by RT-qPCR and western blot, respectively. The functions of β cells in vitro and in vivo were evaluated glucose-stimulated insulin secretion test and HOMA-β, respectively. RESULTS: Ferroptosis occurred in the pancreas of T2DM mice and HG-induced INS-1 cells. Silencing miR-144-3p blocked the effect of HG on the cell viability and accumulation of lipid peroxides, thereby improving the insulin secretion in INS-1 cells. Mechanistically, USP22 is a direct target of miR-144-3p, which could stabilize SIRT1 expression, thereby suppressing ferroptosis. Overexpressing USP22 attenuated deleterious roles of HG in INS-1 cells; but its roles were reversed by up-regulating miR-144-3p. In vivo study demonstrated that miR-144-3p antagomir exerted an anti-hyperglycemic effect and regulated the ferroptosis-related proteins in the pancreas. CONCLUSION: The up-regulation of miR-144-3p suppressed USP22/SIRT1 to induce ferroptosis, which causes pancreatic β cells dysfunction, thereby promoting T2DM development. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13098-022-00852-7. BioMed Central 2022-06-27 /pmc/articles/PMC9235078/ /pubmed/35761309 http://dx.doi.org/10.1186/s13098-022-00852-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Zhang, Shanshan
Liu, Xiao
Wang, Jihong
Yuan, Fengjuan
Liu, Yali
Targeting ferroptosis with miR-144-3p to attenuate pancreatic β cells dysfunction via regulating USP22/SIRT1 in type 2 diabetes
title Targeting ferroptosis with miR-144-3p to attenuate pancreatic β cells dysfunction via regulating USP22/SIRT1 in type 2 diabetes
title_full Targeting ferroptosis with miR-144-3p to attenuate pancreatic β cells dysfunction via regulating USP22/SIRT1 in type 2 diabetes
title_fullStr Targeting ferroptosis with miR-144-3p to attenuate pancreatic β cells dysfunction via regulating USP22/SIRT1 in type 2 diabetes
title_full_unstemmed Targeting ferroptosis with miR-144-3p to attenuate pancreatic β cells dysfunction via regulating USP22/SIRT1 in type 2 diabetes
title_short Targeting ferroptosis with miR-144-3p to attenuate pancreatic β cells dysfunction via regulating USP22/SIRT1 in type 2 diabetes
title_sort targeting ferroptosis with mir-144-3p to attenuate pancreatic β cells dysfunction via regulating usp22/sirt1 in type 2 diabetes
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9235078/
https://www.ncbi.nlm.nih.gov/pubmed/35761309
http://dx.doi.org/10.1186/s13098-022-00852-7
work_keys_str_mv AT zhangshanshan targetingferroptosiswithmir1443ptoattenuatepancreaticbcellsdysfunctionviaregulatingusp22sirt1intype2diabetes
AT liuxiao targetingferroptosiswithmir1443ptoattenuatepancreaticbcellsdysfunctionviaregulatingusp22sirt1intype2diabetes
AT wangjihong targetingferroptosiswithmir1443ptoattenuatepancreaticbcellsdysfunctionviaregulatingusp22sirt1intype2diabetes
AT yuanfengjuan targetingferroptosiswithmir1443ptoattenuatepancreaticbcellsdysfunctionviaregulatingusp22sirt1intype2diabetes
AT liuyali targetingferroptosiswithmir1443ptoattenuatepancreaticbcellsdysfunctionviaregulatingusp22sirt1intype2diabetes